David K Choi

21PUBLICATIONS
17CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Clinical pharmacology and therapeuticsAutoimmunityImmunology not elsewhere classifiedApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jun 09, 2026
Impact of Upadacitinib on Cardiovascular Events and Lipid Values in Older Inflammatory Bowel Disease Patients With Baseline Cardiovascular Risk.

|May 14, 2026
Evaluation of a pharmacist directed treat to target approach in patients with inflammatory bowel disease receiving upadacitinib or risankizumab.

|Aug 22, 2025
New Eczematous Eruption in Patients With Inflammatory Bowel Disease Who Stop Janus Kinase Inhibitors.

Russell Yanofsky, Benjamin D McDonald, Newsha Nikzad

|Nov 07, 2024
Immediate Infusion Reaction to Intravenous Risankizumab-rzaa but Subsequent Tolerance to Subcutaneous Risankizumab-rzaa.

David Choi, Benjamin McDonald, David T Rubin

|May 13, 2024
Impact of a health-system specialty pharmacy on time to upadacitinib initiation.

David Choi, David T Rubin, Bernice Man

|Feb 12, 2024
Mirikizumab: A New Therapeutic Option for the Treatment of Ulcerative Colitis.

David Choi, Hilary Sheridan, Shubha Bhat

Pageof 4

Frequent Collaborators

5 joint publications

David T Rubin

4 joint publications

Shubha Bhat

2 joint publications

Benjamin D McDonald

1 joint publications

Costica Aloman